These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4404822)

  • 41. Structure-activity relationships in 1,4-benzodioxan-related compounds. 5. Effects of modification of the side chain on alpha-adrenoreceptor blocking activity.
    Quaglia W; Giannella M; Marucci G; Piergentili A; Pigini M; Tayebati SK; Melchiorre C
    Farmaco; 1996 Jan; 51(1):27-32. PubMed ID: 8721758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.
    Marshall I; Burt RP; Green GM; Hussain MB; Chapple CR
    Br J Pharmacol; 1996 Sep; 119(2):407-15. PubMed ID: 8886428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Syntheses of cisoid and transoid analogs of phenethylamine.
    Smissman EE; el-Antably S; Hedrich LW; Walaszek EJ; Tseng LF
    J Med Chem; 1973 Feb; 16(2):109-13. PubMed ID: 4734202
    [No Abstract]   [Full Text] [Related]  

  • 44. The mechanism of action of 2-halogenoethylamines at the adrenergic alpha-receptor and a further investigation of the "spare receptor" hypothesis.
    Moran JF; Triggle CR; Triggle DJ
    J Pharm Pharmacol; 1969 Jan; 21(1):38-46. PubMed ID: 4388188
    [No Abstract]   [Full Text] [Related]  

  • 45. Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides.
    Clifton JE; Collins I; Hallett P; Hartley D; Lunts LH; Wicks PD
    J Med Chem; 1982 Jun; 25(6):670-9. PubMed ID: 6124636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.
    Rosini M; Antonello A; Cavalli A; Bolognesi ML; Minarini A; Marucci G; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 2003 Nov; 46(23):4895-903. PubMed ID: 14584940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conformational effects on the activity of drugs. 7. Synthesis and pharmacological properties of 2-(p-nitrophenyl)-substituted morpholines.
    Balsamo A; Crotti P; Lapucci A; Macchia B; Macchia F; Del Tacca M; Mazzanti L; Ceserani R
    J Med Chem; 1979 Jun; 22(6):738-41. PubMed ID: 37340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blockade of adrenergic responses by halogenated phenyl-2-halogenoethyl amines.
    Swamy VC
    Life Sci; 1974 Jun; 14(11):2143-50. PubMed ID: 4847806
    [No Abstract]   [Full Text] [Related]  

  • 49. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens.
    Minneman KP; Fox AW; Abel PW
    Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relative potency of (-)- and (plus-)-salbutamol on guinea pig tracheal tissue.
    Hawkins CJ; Klease GT
    J Med Chem; 1973 Jul; 16(7):856-7. PubMed ID: 4725935
    [No Abstract]   [Full Text] [Related]  

  • 51. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
    Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
    Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On the question of subclassification of -adrenoceptors.
    Janis RA; Triggle DJ
    J Pharm Pharmacol; 1973 Mar; 25(3):263-4. PubMed ID: 4146331
    [No Abstract]   [Full Text] [Related]  

  • 54. Selective blocking properties of chloro acetyl catechol (CAC) on the alpha-adrenergic receptor.
    Huidobro-Toro JP; Carpi A
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):180-92. PubMed ID: 10863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further examination of the inhibitory actions of alpha 1-adrenoceptor agonists in rat vas deferens.
    Warnock P; Hyland L; Docherty JR
    Eur J Pharmacol; 1985 Jul; 113(2):239-45. PubMed ID: 2412843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.
    Lagu B; Tian D; Chiu G; Nagarathnam D; Fang J; Shen Q; Forray C; Ransom RW; Chang RS; Vyas KP; Zhang K; Gluchowski C
    Bioorg Med Chem Lett; 2000 Jan; 10(2):175-8. PubMed ID: 10673105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
    Bolognesi ML; Budriesi R; Chiarini A; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1998 Nov; 41(24):4844-53. PubMed ID: 9822553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absolute configuration of glycerol derivatives. 7. Enantiomers of 2-[[[2-(2,6-dimethoxyphenoxy)ethyl]amino]methyl]-1,4-benzodioxane (WB-4101), a potent competitive alpha-adrenergic antagonist.
    Nelson WL; Powell ML; Dyer DC
    J Med Chem; 1979 Sep; 22(9):1125-7. PubMed ID: 40029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.